Octreotide for Injectable Suspension
Octreotide for Injectable Suspension
Generic name
- octreotide (as acetate)
Brand Reference
- Sandostatin LAR®
Therapeutic Class
- Synthetic octapeptide analogue of somatostatin
Strength
- 30 mg
DIN
- 02503786
Product form
- Powder for Suspension (Sustained Release)
Product Details
Product Code |
UPC |
Pack Size |
|---|---|---|
| 32044036 | 068510998484 | Vial 1 |
Ingredients
Please view the product monograph to find details of all ingredients contained in this product. For additional generic & OTC product inquiries, please call 1-800-268-4127, option 3 or email druginfo@tevacanada.com.
Storage
Store between 2°C - 8°C. Keep vial in the outer carton in order to protect it from light. The vials can remain at room temperature on the day of the injection. However the suspension must only be prepared immediately prior to intramuscular (i.m.) injection. Store the pre-filled syringe with 2 mL diluent at 2°C - 8°C. Do not freeze.
Information
Disclaimer
All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.
Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.
"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves
